Navigation Links
Dysfunctional chemokine receptor promotes candidiasis
Date:11/1/2013

Candida albicans is one of the leading causes of hospital-acquired infections in immune compromised patients. The risk of both developing candidiasis and the clinical outcome of infection is variable among patients, and the host-dependent factors that contribute to patient susceptibility to C. albicans infection are poorly understood. In this issue of the Journal of Clinical Investigation, Michail Lionakis and colleagues at the National Institute of Allergy and Infectious Diseases demonstrated that the chemokine receptor CX3CR1 is required for the interaction of C. albicans and macrophages in the kidney. Mice lacking this receptor were prone to C. albicans-induced kidney failure; however, these mice did not have increased fungal burden in other organs. Furthermore, the authors found that patients with a mutation in the gene encoding CX3CR1 were at higher risk of candidiasis. This study identifies an important role for the interaction of C. albicans and macrophages in disease progression and outcome.


'/>"/>

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related biology news :

1. Has modern science become dysfunctional?
2. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
3. G protein-coupled receptor mediates the action of castor oil
4. BUSM study identifies receptors role in regulating obesity, type 2 diabetes
5. Cell receptor has proclivity for T helper 9 cells, airway inflammation
6. Steroid hormone receptor prefers working alone to shut off immune system genes
7. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
8. Dopamine-receptor gene variant linked to human longevity
9. How the tilt of a cell-surface receptor prevents cancer
10. Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
11. Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2018)... ... September 14, 2018 , ... ... This campaign will showcase the innovative work being done within rare diseases research, ... therapies for those living with rare diseases. , The print ...
(Date:9/12/2018)... ... September 12, 2018 , ... Captiva Spine, Inc., which designs, ... received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ... , TowerLOX-EXT MIS Extended Tab Pedicle Screws provide the narrow insertion of an ...
(Date:9/1/2018)... ... ... Right this minute, Frenchman Ben Lecomte is hard at work on his second ocean crossing. ... a new challenge: going from Tokyo to San Francisco, churning his limbs eight hours a ... boat. As the first expedition of its kind, The Swim is far more than just ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... August 28, 2018 , ... Cognition Corporation ®, ... lineup of talks for NAVIGATE2018 . , Ryan Ward, Director of Engineering ... annual user conference. An experienced engineer and manager with Zimmer Biomet for almost 15 ...
(Date:8/26/2018)... Calif. (PRWEB) , ... August 23, 2018 , ... ... events for tech innovators, engineers, and scientists from around the world, will host ... 2018 will cover an array of industries and disciplines, encompassing various research areas ...
(Date:8/21/2018)... (PRWEB) , ... August 21, 2018 , ... The Connecticut ... an annual recognition of the fastest growing technology companies in Connecticut. This year’s group ... held on Wednesday, October 3, at the Connecticut Convention Center in Hartford. A complete ...
(Date:8/14/2018)... ... August 13, 2018 , ... Labconco Corporation manufactures laboratory equipment, ... In addition, Labconco produces other lab equipment, such as glassware washers and freeze ... and consistency in design and manufacturing. , Through this webinar, which is ...
Breaking Biology Technology: